Former OpenAI exec Fidji Simo discusses her battle with POTS and her startup's plans to cure it with AI and 3,500 vials of blood (11 minute read)

TLDR AI 08/04/26, 12:00 AM News

ai-health startup biotech chronic-disease pots blood-draws

Summary

Former OpenAI exec Fidji Simo discusses her POTS battle and her new startup ChronicleBio, which uses AI and massive blood datasets to cure chronic diseases and improve clinical trials.

Fidji Simo left OpenAI's leadership team after a seven-year battle with Postural Orthostatic Tachycardia Syndrome (POTS). Her new startup, ChronicleBio, will focus on using AI to cure POTS and other chronic diseases. The company has collected 153 terabytes of data from blood draws from people with chronic diseases so far. It plans to launch home blood draws to further increase its dataset. ChronicleBio plans to use the data to learn more about diseases and improve the success of clinical drug trials.

Original Article

Similar Articles

@fidjissimo: While AI gives me a lot of hope to find cures for complex chronic conditions like mine, this potential will only be rea…

X AI KOLs Following

Former OpenAI executive Fidji Simo discusses her new startup ChronicleBio, which aims to use AI and a biobank of 3,500 blood samples to find cures for chronic conditions like POTS.

Fidji Simo steps down from leading OpenAI’s AGI work due to illness

The Verge

Fidji Simo, OpenAI's AGI chief, is stepping down from her full-time role due to a chronic neuroimmune condition and will transition to a part-time advisory position, following a series of executive reshuffles at the company.

OpenAI's No. 2 Executive to Step Down in Latest Leadership Shake-Up (4 minute read)

TLDR AI

OpenAI executive Fidji Simo is stepping down due to a worsening neuroimmune condition, transitioning to a part-time adviser role; her responsibilities will be divided among other executives.

The fittest founder in the room got cancer. Here’s how he used AI to fight back.

TechCrunch AI

Conno Christou, a data-driven founder, was diagnosed with a rare aggressive lymphoma after a chance discovery. He used his quantitative approach—including AI-powered health tracking—to gather multiple medical opinions and choose the most effective treatment, treating his chemotherapy like a startup marathon.

OpenAI’s CEO of AGI Deployment, Fidji Simo, Is Stepping Down

Wired

OpenAI's CEO of AGI Deployment, Fidji Simo, is stepping down from her full-time role to become a part-time adviser due to a chronic health condition, as part of a larger executive reshuffle.